Smart jab can shrink head and neck cancer tumours within six weeks, trial finds
Triple-action therapy drug amivantamab could be given as an injection to help treat recurrent or metastatic cancers Doctors have hailed “incredibly encouraging” trial results that show a triple-action smart jab can shrink tumours in head and neck cancer patients within six weeks. Head and neck (…)
Site référencé:
The Guardian (South&CentralAsia)
3566.jpg?width=140&quality=85&auto=format&fit=max&s=6b8d8aa1d243e52630ec912240d7c64f, 3566.jpg?width=460&quality=85&auto=format&fit=max&s=2d87713509e54a6825bcd7efa979683a, 3566.jpg?width=700&quality=85&auto=format&fit=max&s=0f55e3e23cd4fdddf1f92afd52d64c83
The Guardian (South&CentralAsia)
‘A fashion and art moment’ : how mediums mix at Frieze art fair
17/10/2025
Homes for sale in converted castles in England and Scotland – in pictures
17/10/2025
‘It was as good aged 61 as it had been at 16’ : readers’ favourite trips as older travellers
17/10/2025
Feet first : what to wear with ankle boots
17/10/2025
Age against the machine : what I learned after stripping down for a full body scan
16/10/2025
Night owls versus early birds : who is superior according to science ?
16/10/2025